Skip to main content
Clinical Trials/DRKS00025839
DRKS00025839Not yet recruitingNot Applicable

Evaluation of the physical resilience and change of airways in patients with cystic fibrosis after starting with a new CFTR-modulator therapy

Mukoviszidose AmbulanzKlinik für Kinder und JugendmedizinUniversitätsklinikum Ulm0 sites80 target enrollmentStarted: July 19, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
6 Years to one (—)
Sex
All

Inclusion Criteria

  • cystic fibrosis patient registered in our ambulance

Exclusion Criteria

  • no cystic fibrosis diagnose, not registered in our ambulance

Investigators

Sponsor
Mukoviszidose AmbulanzKlinik für Kinder und JugendmedizinUniversitätsklinikum Ulm

Similar Trials